DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,244,232 | +31.8% | 97,817 | +45.9% | 0.00% | – |
| Q2 2023 | $943,684 | +11.4% | 67,023 | +22.2% | 0.00% | – |
| Q1 2023 | $847,479 | +82.0% | 54,853 | +93.0% | 0.00% | – |
| Q4 2022 | $465,770 | -67.2% | 28,418 | -63.0% | 0.00% | -100.0% |
| Q3 2022 | $1,422,000 | +400.7% | 76,863 | +256.5% | 0.00% | – |
| Q2 2022 | $284,000 | -64.1% | 21,560 | -74.8% | 0.00% | – |
| Q1 2022 | $792,000 | -71.5% | 85,425 | -70.0% | 0.00% | – |
| Q4 2021 | $2,780,000 | +105.2% | 284,563 | +614.0% | 0.00% | – |
| Q3 2021 | $1,355,000 | +232.1% | 39,853 | +337.9% | 0.00% | – |
| Q1 2021 | $408,000 | -73.5% | 9,100 | -66.3% | 0.00% | -100.0% |
| Q4 2020 | $1,542,000 | +94.5% | 26,999 | +74.7% | 0.00% | – |
| Q3 2020 | $793,000 | -24.8% | 15,457 | -12.5% | 0.00% | – |
| Q2 2020 | $1,055,000 | +13.9% | 17,671 | +18.8% | 0.00% | -100.0% |
| Q4 2019 | $926,000 | +336.8% | 14,872 | +137.9% | 0.00% | – |
| Q3 2019 | $212,000 | -80.9% | 6,252 | -77.9% | 0.00% | -100.0% |
| Q2 2018 | $1,112,000 | – | 28,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |